TELA Bio (TELA) Gross Margin (QoQ) (2018 - 2026)
TELA Bio (TELA) Gross Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.00 |
| Dec 31, 2025 | -161.00 |
| Sep 30, 2025 | -232.00 |
| Jun 30, 2025 | 228.00 |
| Mar 31, 2025 | 398.00 |
| Dec 31, 2024 | -425.00 |
| Sep 30, 2024 | -99.00 |
| Jun 30, 2024 | 54.00 |
| Mar 31, 2024 | -11.00 |
| Dec 31, 2023 | -64.00 |
| Sep 30, 2023 | -136.00 |
| Jun 30, 2023 | 406.00 |
| Mar 31, 2023 | -403.00 |
| Dec 31, 2022 | 476.00 |
| Sep 30, 2022 | 264.00 |
| Jun 30, 2022 | 221.00 |
| Mar 31, 2022 | -684.00 |
| Dec 31, 2021 | 745.00 |
| Sep 30, 2021 | -718.00 |
| Jun 30, 2021 | 835.00 |